Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/20297
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLibianto, Renata-
dc.contributor.authorEkinci, Elif I-
dc.date2019-01-23-
dc.date.accessioned2019-03-04T22:04:14Z-
dc.date.available2019-03-04T22:04:14Z-
dc.date.issued2019-04-
dc.identifier.citationCritical Care Clinics 2019; 35(2): 315-328en_US
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/20297-
dc.description.abstractThe Renaissance of glucose-lowering therapies has arrived with multiple agents that lower blood glucose and demonstrate cardiovascular and renal benefits in people with type 2 diabetes. This article summarizes these new classes of therapies, including the sodium glucose co-transporter-2 inhibitors, glucagon-like peptide-1 agonists, and dipeptidyl peptidase-4 inhibitors. Their cardiovascular safety profile, effects on glycemic, weight, and renal outcomes are discussed. As more options become available to treat type 2 diabetes, clinicians need to be aware of the advantages of each class of medications, beyond their glycemic lowering effects. The safety profiles are summarized in this article.en_US
dc.language.isoeng-
dc.subjectDPP-4 inhibitorsen_US
dc.subjectDiabetesen_US
dc.subjectGLP-1 agonistsen_US
dc.subjectNew treatmenten_US
dc.subjectSGLT-2 inhibitorsen_US
dc.titleNew Agents for the Treatment of Type 2 Diabetes.en_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleCritical Care Clinicsen_US
dc.identifier.affiliationEndocrinologyen_US
dc.identifier.affiliationMedicine (University of Melbourne)en_US
dc.identifier.doi10.1016/j.ccc.2018.11.007en_US
dc.type.contentTexten_US
dc.identifier.orcid0000-0003-2372-395Xen_US
dc.identifier.pubmedid30784612-
dc.type.austinJournal Article-
dc.type.austinReview-
local.name.researcherEkinci, Elif I
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.languageiso639-1en-
item.openairetypeJournal Article-
crisitem.author.deptEndocrinology-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

10
checked on Mar 28, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.